Downloadable Slideset

Share

Program Content

Activities

  • EBC: Utility of Ki67 Testing
    Optimal Utilization of Ki67 Testing in HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Oncology and Pathology Healthcare Teams
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 04, 2022

    Expires: March 03, 2023

    View Activity

Faculty

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director
Susan F. Smith Center for Women's Cancers
Senior Physician
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Lilly